The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 2, 2011-01 ,pp. : 242-246

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the ubiquitin–proteasome pathway in breast cancer therapy

By Dees E Claire   Orlowski Robert Z  

Future Oncology, Vol. 2, Iss. 1, 2006-02 ,pp. : 121-135

Future Medicine

Access to resources Recommend Favorite

Targeting the Ubiquitin-Proteasome Pathway in Cancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 7, Iss. 3, 2007-05 ,pp. : 359-365

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 8, 2012-10 ,pp. : 891-901

Bentham Science Publishers

Access to resources Recommend Favorite

Anorexia–Cachexia syndrome in cancer: implications of the ubiquitin–proteasome pathway

By Camps Carlos   Iranzo Vega   Bremnes Roy   Sirera Rafael  

Supportive Care in Cancer, Vol. 14, Iss. 12, 2006-12 ,pp. : 1173-1183

Springer Publishing Company

Access to resources Recommend Favorite